Role of tannin-rich plant fractions in hepatoprotection: a nanotechnology perspective
Source abstract
Abstract
The liver, a vital organ for metabolic and detoxification processes, is often vulnerable to damage from toxins, drugs, and diseases. Tannins, a class of polyphenolic compounds found in various plants, exhibit promising hepatoprotective properties by enhancing liver cell viability and function, mitigating oxidative stress, and promoting anti-apoptotic, anti-inflammatory, and detoxifying effects. These phenolic compounds effectively protect against liver injuries. However, their clinical utility is hampered by poor bioavailability, rapid metabolism, and stability issues. This review explores the role of tannin-rich plant fractions in hepatoprotection. The hepatoprotective potential of these compounds is increasingly recognized, particularly through the lens of nanotechnology, which can improve the delivery and absorption of tannin-rich extracts, maximizing their therapeutic potential. Advances in nanocarriers, including nanoparticles, nanoemulsions, and liposomes, have demonstrated improved bioavailability, targeted delivery, and sustained release of tannins, offering a promising avenue for hepatoprotective therapy. Nanotechnology can be engineered to target liver cells specifically, increasing the efficacy of tannin-based treatments while minimizing side effects. Preclinical and clinical insights, regulatory considerations, and future directions for tannin-based nanotherapeutics are discussed, highlighting their potential impact. Studies show that tannin-rich extracts lower serum levels of liver enzymes (ALT, AST) and it is revealed that Tannic Acid can enhance hepatic function at specific additive concentrations and even when injured by Acetaminophen, hepatocytes could revert to their preinjury state after additional Tannic Acid supplementation, and holds clinical potential in the treatment of Acetaminophen induced liver failure, indicating reduced liver damage. While the hepatoprotective properties of tannin-rich plant fractions are promising, challenges remain regarding the standardization and safety of these natural products. Further research is essential to fully understand their mechanisms and optimize their clinical applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Drug-Induced Hepatotoxicity and Protection · Phytochemicals and Antioxidant Activities · Chemotherapy-induced organ toxicity mitigation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (88)
Show source-provided references
1. Aladejana EB, Aladejana AE. Hepatoprotective activities of polyherbal formulations: A systematic review. J Med Plants Econ Dev. 2023. https://doi.org/10.4102/jomped.v7i1.206.10.4102/jomped.v7i1.206 ↗
2. Byrne CD, Targher G. NAFLD: A multisystem disease. J Hepatol. 2015;62:S47–64.10.1016/j.jhep.2014.12.012 ↗
3. Kouipou Toghueo RM, Boyom FF. Endophytic fungi from terminalia species: A comprehensive review. J Fungi. 2019;5:43.10.3390/jof5020043 ↗
4. Grewal S, Tiwary N, Malik G, Garg M, Deswal G, Chopra B, Grewal AS, Dhingra AK, Guarve K. Decoding therapeutic applications of quercetin: recent advancements in Nanotechnological strategies. Pharm Nanotechnol. 2025;13:596–617.10.2174/0122117385271262231114075737 ↗
5. Fraga-Corral M, Otero P, Cassani L, Echave J, Garcia-Oliveira P, Carpena M, Chamorro F, Lourenço-Lopes C, Prieto MA, Simal-Gandara J. Traditional applications of tannin rich extracts supported by scientific data: chemical composition. Bioavailab Bioaccessibility Foods. 2021;10:251.
6. Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano. 2009;3:16–20.10.1021/nn900002m ↗
7. Alshawwa SZ, Kassem AA, Farid RM, Mostafa SK, Labib GS. Nanocarrier drug delivery systems: Characterization, Limitations, future perspectives and implementation of artificial intelligence. Pharmaceutics. 2022;14:883.10.3390/pharmaceutics14040883 ↗
8. Luqman Adepoju H, Godson Emeka A, Afisu B, Asekun-Olarinmoye IO, Shettima Pogu A, Cyril Abang A. (2024) Tannin-Rich fraction of Cyperus esculentus protects against Lead-Induced testicular toxicity in male Wistar rats through ITS antioxidant properpty. Res J Pharmacol Pharmacodyn 137–42.10.52711/2321-5836.2024.00024 ↗
9. Patel J, Roy H, Khobragade DS, Agrawal S, Das NR, Patel R, Patel V, Lal P. Natural lipid-based nanoformulations for enhancing hepatoprotective activity: mechanisms, efficacy, and clinical translation. Health Nanotechnol. 2025;1:11.10.1186/s44301-025-00010-8 ↗
10. Rodríguez-Hernández P, Reyes-Palomo C, Sanz-Fernández S, Rufino-Moya PJ, Zafra R, Martínez-Moreno FJ, Rodríguez-Estévez V, Díaz-Gaona C. Antiparasitic Tannin-Rich plants from the South of Europe for grazing livestock: A review. Animals. 2023;13:201.10.3390/ani13020201 ↗
11. Maroyi A. Review of Ethnomedicinal, phytochemical and Pharmacological properties of Lannea schweinfurthii (Engl.) engl. Molecules. 2019;24:732.10.3390/molecules24040732 ↗
12. Wiart C, Tan PL, Rajagopal M, Chew Y-L, Leong MY, Tan LF, Yap VL. Review of Malaysian medicinal plants with potential wound healing activity. BMC Complement Med Ther. 2024;24:268.10.1186/s12906-024-04548-5 ↗
13. Jing W, Xiaolan C, Yu C, Feng Q, Haifeng Y. Pharmacological effects and mechanisms of Tannic acid. Biomed Pharmacother. 2022;154:113561.10.1016/j.biopha.2022.113561 ↗
14. Kleszcz R, Majchrzak-Celińska A, Baer‐Dubowska W. Tannins in cancer prevention and therapy. Br J Pharmacol. 2025;182:2075–93.10.1111/bph.16224 ↗
15. Ibrahim ND, Seow LJ, Sekar M, Izzati Mat Rani NN, Lum PT. Ten commonly available medicinal plants in Malaysia with potential sun protection factor and antioxidant Properties – A review. Pharmacogn J. 2022;14:444–55.10.5530/pj.2022.14.57 ↗
16. Rira M, Morgavi DP, Popova M, Maxin G, Doreau M. (2022) Microbial colonisation of tannin-rich tropical plants: Interplay between degradability, methane production and tannin disappearance in the rumen. animal 16:100589.10.1016/j.animal.2022.100589 ↗
17. Iqbal N, Poór P. Plant protection by tannins depends on Defence-Related phytohormones. J Plant Growth Regul. 2025;44:22–39.10.1007/s00344-024-11291-1 ↗
18. Petrovic S, Bita B, Barbinta-Patrascu M-E. Nanoformulations in pharmaceutical and biomedical applications: green perspectives. Int J Mol Sci. 2024;25:5842.10.3390/ijms25115842 ↗
19. Koopmann A-K, Schuster C, Torres-Rodríguez J, Kain S, Pertl-Obermeyer H, Petutschnigg A, Hüsing N. Tannin-Based hybrid materials and their applications: A review. Molecules. 2020;25:4910.10.3390/molecules25214910 ↗
20. Xia M, Jiang W, Wu C, Wang C, Yoo CG, Liu Y, Lyu G. Tannin-Assisted synthesis of nanocomposites loaded with silver nanoparticles and their multifunctional applications. Biomacromolecules. 2023;24:5194–206.10.1021/acs.biomac.3c00737 ↗
21. Shahidi F, Samarasinghe A. How to assess antioxidant activity? Advances, limitations, and applications of in vitro, in vivo, and ex vivo approaches. Food Prod Process Nutr. 2025;7:50.10.1186/s43014-025-00326-z ↗
22. Yeo J, Lee J, Yoon S, Kim WJ. Tannic acid-based nanogel as an efficient anti-inflammatory agent. Biomater Sci. 2020;8:1148–59.10.1039/C9BM01384A ↗
23. Molinaro G, Fontana F, Pareja Tello R, et al. In vitro study of the Anti-inflammatory and antifibrotic activity of Tannic Acid-Coated Curcumin-Loaded nanoparticles in human tenocytes. ACS Appl Mater Interfaces. 2023;15:23012–23.10.1021/acsami.3c05322 ↗
24. Padmanaban S, Pully D, Samrot AV, Gosu V, Sadasivam N, Park I-K, Radhakrishnan K, Kim D-K. Rising influence of nanotechnology in addressing oxidative Stress-Related liver disorders. Antioxidants. 2023;12:1405.10.3390/antiox12071405 ↗
25. Blenn C, Wyrsch P, Althaus FR. The ups and downs of tannins as inhibitors of Poly(ADP-Ribose)glycohydrolase. Molecules. 2011;16:1854–77.10.3390/molecules16021854 ↗
26. Ali T, Hussain F, Naeem M, Khan A, Al-Harrasi A. Nanotechnology approach for exploring the enhanced bioactivities and biochemical characterization of freshly prepared Nigella sativa L. Nanosuspensions and their phytochemical profile. Front Bioeng Biotechnol. 2022;10:888177.10.3389/fbioe.2022.888177 ↗
27. Ali H, Jahan A, Samrana S, et al. Hepatoprotective potential of pomegranate in curbing the incidence of acute liver injury by alleviating oxidative stress and inflammatory response. Front Pharmacol. 2021;12:694607.10.3389/fphar.2021.694607 ↗
28. Hamad Shareef S, Abdel Aziz Ibrahim I, Alzahrani AR, Al-Medhtiy MH, Ameen Abdulla M. Hepatoprotective effects of methanolic extract of green tea against Thioacetamide-Induced liver injury in Sprague Dawley rats. Saudi J Biol Sci. 2022;29:564–73.10.1016/j.sjbs.2021.09.023 ↗
29. Huang C-Z, Tung Y-T, Hsia S-M, Wu C-H, Yen G-C. The hepatoprotective effect of phyllanthus emblica L. fruit on high fat diet-induced non-alcoholic fatty liver disease (NAFLD) in SD rats. Food Funct. 2017;8:842–50.10.1039/C6FO01585A ↗
30. Wunnoo S, Sermwittayawong D, Praparatana R, Voravuthikunchai SP, Jakkawanpitak C. Quercus infectoria gall ethanolic extract accelerates wound healing through attenuating inflammation and oxidative injuries in skin fibroblasts. Antioxidants. 2024;13:1094.10.3390/antiox13091094 ↗
31. Idrees M, Javaid S, Nadeem S, Khurshid F, Parveen A, Malik A, Ali Khan A, Akhtar S, Fatima S. (2024) Antimicrobial and Hepatoprotective Properties of Pods of Acacia nilotica (L.) Willd. ex Delile: In Vivo and In Silico Approaches. Dose-Response 22:15593258241308998.10.1177/15593258241308998 ↗
32. (2024) A review of spondias pinnata (L.f.) kurz’s phytochemical Constituents, traditional Uses, and Pharmacological activities: an important medicinal plant in ayurveda. TEXILA Int J PUBLIC Health. https://doi.org/10.21522/TIJPH.2013.SE.24.05.Art02210.21522/TIJPH.2013.SE.24.05.Art022 ↗
33. Ambwani S, Chand P, Kumawat SK, Singh H, Koranga D. In vitro analysis of antioxidant capacity of bauhinia variegata (L.) Benth leaf extract. Pharmacol Res - Nat Prod. 2025;8:100350.
34. Williams AR, Fryganas C, Ramsay A, Mueller-Harvey I, Thamsborg SM. Direct anthelmintic effects of condensed tannins from diverse plant sources against Ascaris suum. PLoS ONE. 2014;9:e97053.10.1371/journal.pone.0097053 ↗
35. Wang B, Wu K, Liu R, et al. Phyllanthi tannin loaded solid lipid nanoparticles for lung cancer therapy: Preparation, Characterization, pharmacodynamics and safety evaluation. Molecules. 2023;28:7399.10.3390/molecules28217399 ↗
36. Wei X, Luo C, He Y, et al. Hepatoprotective effects of different extracts from Triphala against CCl4-Induced acute liver injury in mice. Front Pharmacol. 2021;12:664607.10.3389/fphar.2021.664607 ↗
37. Feng X-H, Xu H-Y, Wang J-Y, Duan S, Wang Y-C, Ma C-M. In vivo hepatoprotective activity and the underlying mechanism of chebulinic acid from terminalia chebula fruit. Phytomedicine. 2021;83:153479.10.1016/j.phymed.2021.153479 ↗
38. Tangestani H, Jamshidi A, Farhadi A, Ghalandari H, Dehghani P, Moghaddas N, Safaei Z, Emamat H. The effects of pomegranate (Punica granatum) on nonalcoholic fatty liver disease: A systematic review of in vivo interventional studies. Phytother Res. 2024;38:4189–201.10.1002/ptr.8272 ↗
39. Jacob S, Kather FS, Boddu SHS, Shah J, Nair AB. Innovations in nanoemulsion technology: enhancing drug delivery for Oral, Parenteral, and ophthalmic applications. Pharmaceutics. 2024;16:1333.10.3390/pharmaceutics16101333 ↗
40. Yuan S, Friedman DL, Daniels AB. Evolution of chemotherapy approaches for the treatment of intraocular retinoblastoma: A comprehensive review. Int Ophthalmol Clin. 2017;57:117–28.10.1097/IIO.0000000000000155 ↗
41. Van Tienderen GS, Berthel M, Yue Z, Cook M, Liu X, Beirne S, Wallace GG. Advanced fabrication approaches to controlled delivery systems for epilepsy treatment. Expert Opin Drug Deliv. 2018;15:915–25.10.1080/17425247.2018.1517745 ↗
42. Tasduq SA, Singh K, Satti NK, Gupta DK, Suri KA, Johri RK. Terminalia chebula (fruit) prevents liver toxicity caused by sub-chronic administration of rifampicin, Isoniazid and Pyrazinamide in combination. Hum Exp Toxicol. 2006;25:111–8.10.1191/0960327106ht601oa ↗
43. Taganna JC, Quanico JP, Perono RMG, Amor EC, Rivera WL. Tannin-rich fraction from terminalia Catappa inhibits quorum sensing (QS) in chromobacterium violaceum and the QS-controlled biofilm maturation and LasA staphylolytic activity in Pseudomonas aeruginosa. J Ethnopharmacol. 2011;134:865–71.10.1016/j.jep.2011.01.028 ↗
44. Deb A, Gupta S, Shekhawat GS, Mazumder PB. A study on exosome based delivery of terminalia chebula Retz. Fruit extract in hepatocellular carcinoma. Pharmacol Res - Nat Prod. 2024;3:100053.
45. Gao J, Xu C, Zhu J. Towards personalized medicine for chronic liver disease. J Pers Med. 2023;13:1432.10.3390/jpm13101432 ↗
46. Chen S, Chen Z, Wang Y, Hao W, Yuan Q, Zhou H, Gao C, Wang Y, Wu X, Wang S. Targeted delivery of Chinese herb pair-based berberine/tannin acid self-assemblies for the treatment of ulcerative colitis. J Adv Res. 2022;40:263–76.10.1016/j.jare.2021.11.017 ↗
47. Molino S, Lerma-Aguilera A, Gómez-Mascaraque LG, Rufián-Henares JÁ, Francino MP. Evaluation of Tannin-Delivery approaches for gut microbiota modulation: comparison of Pectin-Based microcapsules and unencapsulated extracts. J Agric Food Chem. 2023;71:13988–99.10.1021/acs.jafc.3c02949 ↗
48. Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V. PLGA-based nanoparticles: an overview of biomedical applications. J Controlled Release. 2012;161:505–22.10.1016/j.jconrel.2012.01.043 ↗
49. Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65:36–48.10.1016/j.addr.2012.09.037 ↗
50. Shah S, Dhawan V, Holm R, Nagarsenker MS, Perrie Y. Liposomes: advancements and innovation in the manufacturing process. Adv Drug Deliv Rev. 2020;154–155:102–22.10.1016/j.addr.2020.07.002 ↗
51. Chen Y, Feng X. Gold nanoparticles for skin drug delivery. Int J Pharm. 2022;625:122122.10.1016/j.ijpharm.2022.122122 ↗
52. Bose AL, Bhattacharjee D, Goswami D. Mixed micelles and bicontinuous microemulsions: promising media for enzymatic reactions. Colloids Surf B Biointerfaces. 2022;209:112193.10.1016/j.colsurfb.2021.112193 ↗
53. Male D, Gromnicova R. Nanocarriers for delivery of oligonucleotides to the CNS. Int J Mol Sci. 2022;23:760.10.3390/ijms23020760 ↗
54. Garg A, Agrawal R, Singh Chauhan C, Deshmukh R. In-situ gel: A smart carrier for drug delivery. Int J Pharm. 2024;652:123819.10.1016/j.ijpharm.2024.123819 ↗
55. Focsan AL, Polyakov NE, Kispert LD. Supramolecular carotenoid complexes of enhanced solubility and Stability—The way of bioavailability improvement. Molecules. 2019;24:3947.10.3390/molecules24213947 ↗
56. Elsabagh SS, Elkhatib EA, Rashad M. Novel nano-fertilizers derived from drinking water industry waste for sustained release of macronutrients: performance, kinetics and sorption mechanisms. Sci Rep. 2024;14:5691.10.1038/s41598-024-56274-0 ↗
57. Mignani S, Shi X, Guidolin K, Zheng G, Karpus A, Majoral J-P. Clinical diagonal translation of nanoparticles: case studies in dendrimer nanomedicine. J Controlled Release. 2021;337:356–70.10.1016/j.jconrel.2021.07.036 ↗
58. Javdani H, Etemad L, Moshiri M, Zarban A, Hanafi-Bojd MY. Effect of Tannic acid-templated mesoporous silica nanoparticles on iron-induced oxidative stress and liver toxicity in rats. Toxicol Rep. 2021;8:1721–8.10.1016/j.toxrep.2021.09.005 ↗
59. Hassan SA, Hammam O, Hussein SA, Aziz WM. (2020) The conquering influence of the nano extracts of pomegranate peels and pistachio leaves in amelioration of acute liver failure. https://doi.org/10.1101/2020.05.06.07100110.1101/2020.05.06.071001 ↗
60. Maslizan M, Haris MS, Ajat M, Md Jamil SNA, Azhar SC, Zahid NI, Mat Azmi ID. Non-lamellar lyotropic liquid crystalline nanoparticles as nanocarriers for enhanced drug encapsulation of Atorvastatin calcium and proanthocyanidins. Chem Phys Lipids. 2024;260:105377.10.1016/j.chemphyslip.2024.105377 ↗
61. Erfi̇Dan MA, Küpeli̇ Akkol E, Sevi̇Mli̇ A, Ci̇Velek T. Effects of pomegranate (Punica granatum L.) on Paracetamol induced acute hepatic damage in mice. Kocatepe Vet J. 2016;9:273–80.10.5578/kvj.28156 ↗
62. Radeva-Ilieva M, Stoeva S, Hvarchanova N, Georgiev KD. Green tea: current knowledge and issues. Foods. 2025;14:745.10.3390/foods14050745 ↗
63. Li H, Liang J, Han M, Gao Z. Polyphenols synergistic drugs to ameliorate non-alcoholic fatty liver disease via signal pathway and gut microbiota: A review. J Adv Res. 2025;68:43–62.10.1016/j.jare.2024.03.004 ↗
64. Alanazi AZ, Algahtani MM, Alotaibi FA, et al. Investigation of the hepatoprotective potential of liposomal Resveratrol as polyphenols against liver damage in streptozotocin diabetic rat model. Int J Med Sci. 2025;22:3380–92.10.7150/ijms.109115 ↗
65. Luo F, Zhu B, Wu D, Xu Y, Chen T, Li Y, Hu J. Construction of Phlorotannin-Based nanoparticles for alleviating acute liver injury. ACS Appl Mater Interfaces. 2023;15:47338–49.10.1021/acsami.3c05407 ↗
66. Sobeh M, Mahmoud MF, Hasan RA, Abdelfattah MAO, Sabry OM, Ghareeb MA, El-Shazly AM, Wink M. Tannin-rich extracts from Lannea stuhlmannii and Lannea humilis (Anacardiaceae) exhibit hepatoprotective activities in vivo via enhancement of the anti-apoptotic protein Bcl-2. Sci Rep. 2018;8:9343.10.1038/s41598-018-27452-8 ↗
67. Özturk N, Ceylan H, Demir Y. The hepatoprotective potential of Tannic acid against doxorubicin-induced hepatotoxicity: insights into its antioxidative, anti‐inflammatory, and antiapoptotic mechanisms. J Biochem Mol Toxicol. 2024;38:e23798.10.1002/jbt.23798 ↗
68. Mohamadi S, Karimi S, Tavallali V. Differential responses of green-synthesized iron nano-complexes in mitigating bicarbonate stress in almond trees. Heliyon. 2024;10:e25322.10.1016/j.heliyon.2024.e25322 ↗
69. Sekowski S, Naziris N, Chountoulesi M, Olchowik-Grabarek E, Czerkas K, Veiko A, Abdulladjanova N, Demetzos C, Zamaraeva M. Interaction of Rhus typhina tannin with lipid nanoparticles: implication for the formulation of a tannin–Liposome hybrid biomaterial with antibacterial activity. J Funct Biomater. 2023;14:296.10.3390/jfb14060296 ↗
70. Salminen J-P. Two-Dimensional tannin fingerprints by liquid chromatography tandem mass spectrometry offer a new dimension to plant tannin analyses and help to visualize the tannin diversity in plants. J Agric Food Chem. 2018;66:9162–71.10.1021/acs.jafc.8b02115 ↗
71. Sharma S. Current status of herbal product: regulatory overview. J Pharm Bioallied Sci. 2015;7:293.10.4103/0975-7406.168030 ↗
72. Rodríguez-Gómez FD, Monferrer D, Penon O, Rivera-Gil P. Regulatory pathways and guidelines for nanotechnology-enabled health products: a comparative review of EU and US frameworks. Front Med. 2025;12:1544393.10.3389/fmed.2025.1544393 ↗
73. Foulkes R, Man E, Thind J, Yeung S, Joy A, Hoskins C. The regulation of nanomaterials and nanomedicines for clinical application: current and future perspectives. Biomater Sci. 2020;8:4653–64.10.1039/D0BM00558D ↗
74. Ekambaram SP, Babu KB, Perumal SS, Rajendran D. Repeated oral dose toxicity study on hydrolysable tannin rich fraction isolated from fruit pericarps of terminalia chebula Retz in Wistar albino rats. Regul Toxicol Pharmacol. 2018;92:182–8.10.1016/j.yrtph.2017.12.001 ↗
75. Hlaing CB, Chariyakornkul A, Pilapong C, Punvittayagul C, Srichairatanakool S, Wongpoomchai R. Assessment of systemic Toxicity, Genotoxicity, and early phase hepatocarcinogenicity of iron (III)-Tannic acid nanoparticles in rats. Nanomaterials. 2022;12:1040.10.3390/nano12071040 ↗
76. Lei W, Yang C, Wu Y, Ru G, He X, Tong X, Wang S. Nanocarriers surface engineered with cell membranes for cancer targeted chemotherapy. J Nanobiotechnol. 2022;20:45.10.1186/s12951-022-01251-w ↗
77. Lotfipour F, Shahi S, Farjami A, Salatin S, Mahmoudian M, Dizaj SM. (2021) Safety and Toxicity Issues of Therapeutically Used Nanoparticles from the Oral Route. BioMed Res Int 2021:9322282.10.1155/2021/9322282 ↗
78. Esmaeely Neisiany R, Enayati M, Das O. Tannic acid-based platforms for biomedical applications. Mater Chem Horiz. 2024;3:1–10.10.61186/MCH.2024.1064 ↗
79. Cristani M, Citarella A, Carnamucio F, Micale N. Nano-Formulations of natural antioxidants for the treatment of liver cancer. Biomolecules. 2024;14:1031.10.3390/biom14081031 ↗
80. Mehta J, Pathania K, Pawar SV. Recent overview of nanotechnology based approaches for targeted delivery of nutraceuticals. Sustain Food Technol. 2025;3:947–78.10.1039/D5FB00122F ↗
81. Delimont NM, Haub MD, Lindshield BL. The impact of tannin consumption on iron bioavailability and status: A narrative review. Curr Dev Nutr. 2017;1:1–12.10.3945/cdn.116.000042 ↗
82. Serrano J, Puupponen-Pimiä R, Dauer A, Aura A, Saura‐Calixto F. Tannins: current knowledge of food sources, intake, bioavailability and biological effects. Mol Nutr Food Res. 2009. https://doi.org/10.1002/mnfr.200900039.10.1002/mnfr.200900039 ↗
83. Ghasemian M, Kazeminava F, Naseri A, Mohebzadeh S, Abbaszadeh M, Kafil HS, Ahmadian Z. Recent progress in Tannic acid based approaches as a natural polyphenolic biomaterial for cancer therapy: A review. Biomed Pharmacother. 2023;166:115328.10.1016/j.biopha.2023.115328 ↗
84. Abaszadeh F, Ashoub MH, Khajouie G, Amiri M. Nanotechnology development in surgical applications: recent trends and developments. Eur J Med Res. 2023;28:537.10.1186/s40001-023-01429-4 ↗
85. Yao J, Feng J, Chen J. External-stimuli responsive systems for cancer theranostic. Asian J Pharm Sci. 2016;11:585–95.
86. Adir O, Poley M, Chen G, Froim S, Krinsky N, Shklover J, Shainsky-Roitman J, Lammers T, Schroeder A. Integrating artificial intelligence and nanotechnology for precision cancer medicine. Adv Mater. 2020;32:1901989.10.1002/adma.201901989 ↗
87. Masara B, Van Der Poll JA, Maaza M. A nanotechnology-foresight perspective of South Africa. J Nanoparticle Res. 2021;23:92.10.1007/s11051-021-05193-6 ↗
88. Patel J, Roy H, Chintamaneni PK, Patel R, Bohara R. Advanced strategies in enhancing the hepatoprotective efficacy of natural products: integrating Nanotechnology, Genomics, and mechanistic insights. ACS Biomater Sci Eng. 2025;11:2528–49.10.1021/acsbiomaterials.5c00004 ↗